600767.SS

Winsan (Chengdu) Medical Science and Technology Co., Ltd. [600767.SS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

600767.SS Stock Summary

In the News

600767.SS Financial details

Company Rating
Neutral
Market Cap
143.22M
Income
-38.31M
Revenue
43.6M
Book val./share
0.57
Cash/share
0.15
Dividend
-
Dividend %
-
Employees
53
Optionable
No
Shortable
Yes
Earnings
27 Apr 2021
P/E
-3.73
Forward P/E
-
PEG
0.06
P/S
3.28
P/B
0.73
P/C
-
P/FCF
-3.72
Quick Ratio
1.4
Current Ratio
1.55
Debt / Equity
0.06
LT Debt / Equity
0.03
-
-
EPS (TTM)
-0.11
EPS next Y
-
EPS next Q
-
EPS this Y
-600%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-25.92%
Revenue Q/Q
-39.19%
EPS Q/Q
-83.73%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-14%
ROE
-17%
ROC
-0.18%
Gross Margin
50%
Oper. Margin
-88%
Profit Margin
-88%
Payout
-1%
Shs Outstand
341.01M
Shs Float
248.1M
-
-
-
-
Target Price
-
52W Range
0.38-6.38
52W High
-
52W Low
-
RSI
-
Rel Volume
3.55
Avg Volume
6.43M
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.561301
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

600767.SS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.610.390.140.140.14
Net income per share
0.06-0.240.030.04-0.1
Operating cash flow per share
-0.12-0.120.110.01-0.04
Free cash flow per share
-0.2-0.140.110.01-0.04
Cash per share
0.30.110.110.110.2
Book value per share
0.840.630.650.650.59
Tangible book value per share
0.40.540.540.590.53
Share holders equity per share
0.840.630.650.650.59
Interest debt per share
0.010.030.010.020.04
Market cap
1.62B1.63B984.6M2.8B1.6B
Enterprise value
1.54B1.59B940.27M2.76B1.56B
P/E ratio
79.17-19.79102.14206.24-45.15
Price to sales ratio
7.7912.2820.2354.0234.5
POCF ratio
-40.37-38.7426.8841.72-117.76
PFCF ratio
-24.06-34.7427.21.03K-116.88
P/B Ratio
5.647.64.411.547.92
PTB ratio
5.647.64.411.547.92
EV to sales
7.4111.9919.3253.2733.72
Enterprise value over EBITDA
36.16-99.4339.57119.08223.42
EV to operating cash flow
-38.41-37.8125.59830.02-115.11
EV to free cash flow
-22.89-33.9125.981.02K-114.25
Earnings yield
0.01-0.050.010-0.02
Free cash flow yield
-0.04-0.030.040-0.01
Debt to equity
0.010.0300.030.07
Debt to assets
0.010.0200.020.04
Net debt to EBITDA
-1.852.44-1.87-1.68-5.16
Current ratio
1.741.481.381.821.54
Interest coverage
22.2-15.9213.134.49-0.03
Income quality
-1.960.513.450.220.38
Dividend Yield
00000
Payout ratio
0.02-0.020.130.08-0.01
Sales general and administrative to revenue
0.110.190.130.090.31
Research and developement to revenue
0.040.07000
Intangibles to total assets
0.380.130.120.080.06
Capex to operating cash flow
0.680.11-0.01-0.180.01
Capex to revenue
-0.13-0.04-0.01-0.010
Capex to depreciation
-1.85-0.28-0.07-0.09-0.01
Stock based compensation to revenue
00000
Graham number
1.071.850.640.731.17
ROIC
0.03-0.180.050.050
Return on tangible assets
0.07-0.250.030.05-0.12
Graham Net
-0.14-0.02-0.040.060.07
Working capital
102.98M61.36M33.41M53.42M44.54M
Tangible asset value
137.45M183.66M186.93M220.08M182.02M
Net current asset value
73.68M43.01M14.93M48.06M24.65M
Invested capital
0.010.0300.030.07
Average receivables
062.2M94.89M65.77M67.22M
Average payables
49.12M37M30.25M23.53M9.38M
Average inventory
37.45M24.36M11.14M6.39M6M
Days sales outstanding
0342.7490.2465.69538.83
Days payables outstanding
160.3680.76610.1148.13165.96
Days of inventory on hand
107.4950.91131.7176.18124.53
Receivables turnover
01.070.740.780.68
Payables turnover
2.284.520.62.462.2
Inventory turnover
3.47.172.774.792.93
ROE
0.07-0.380.040.06-0.18
Capex per share
-0.08-0.01000

Quarterly Fundamentals Overview

Last date of statement is 2023-03-31 for Q1

Metric History 2022-03-312022-06-302022-09-302022-12-31 2023-03-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.020.020.050.030.02
Net income per share
-0.0100.02-0.11-0.02
Operating cash flow per share
-0.0600.02-0.11-0.02
Free cash flow per share
-0.0600.02-0.11-0.02
Cash per share
0.110.110.120.20.15
Book value per share
0.610.610.630.590.57
Tangible book value per share
0.560.560.580.530.52
Share holders equity per share
0.610.610.630.590.57
Interest debt per share
0.050.040.060.040.04
Market cap
2.55B1.53B2.11B1.6B1.89B
Enterprise value
2.55B1.53B2.11B1.56B1.87B
P/E ratio
-146.41-278.281.21-10.68-77.54
Price to sales ratio
273.41197.4116.41145.11282.57
POCF ratio
-114.9-1.11K324.84-42.71-310.16
PFCF ratio
-114.87-1.1K326.75-42.66-303.26
P/B Ratio
10.686.448.667.929.66
PTB ratio
10.686.448.667.929.66
EV to sales
272.79196.75116.24141.84279.7
Enterprise value over EBITDA
-639.43-847.01248.34-563.41-369.34
EV to operating cash flow
-114.64-1.11K324.38-41.75-307.01
EV to free cash flow
-114.61-1.1K326.28-41.7-300.19
Earnings yield
000-0.020
Free cash flow yield
-0.0100-0.020
Debt to equity
0.080.070.090.070.06
Debt to assets
0.060.050.070.040.04
Net debt to EBITDA
1.452.78-0.3613.013.79
Current ratio
1.881.911.791.541.55
Interest coverage
-13.21-8.7320.61-86.6-38.29
Income quality
5.71111
Dividend Yield
00000
Payout ratio
-0.01-0.040.0200
Sales general and administrative to revenue
0.97-0.080.57-0.41.17
Research and developement to revenue
00000
Intangibles to total assets
0.080.070.060.060.07
Capex to operating cash flow
00.01-0.0100.02
Capex to revenue
0000-0.02
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
0.390.220.491.20.48
ROIC
-0.02-0.010.03-0.17-0.03
Return on tangible assets
-0.0200.02-0.13-0.02
Graham Net
0.080.080.090.070.05
Working capital
47M46.9M54.12M44.54M35.71M
Tangible asset value
216.95M216.9M225.92M182.02M177.15M
Net current asset value
32.79M33.48M40.64M24.65M17.14M
Invested capital
0.080.070.090.070.06
Average receivables
070.49M80.78M79.57M64.34M
Average payables
010.69M10.52M10.28M7.36M
Average inventory
04.47M4.46M5.98M7.82M
Days sales outstanding
677.87820.58450.15558.9813.23
Days payables outstanding
207.1167.63193.12134.5597.44
Days of inventory on hand
85.0871.2781.74100.95168.14
Receivables turnover
0.130.110.20.160.11
Payables turnover
0.430.540.470.670.92
Inventory turnover
1.061.261.10.890.54
ROE
-0.02-0.010.03-0.19-0.03
Capex per share
00000

600767.SS Frequently Asked Questions

What is Winsan (Chengdu) Medical Science and Technology Co., Ltd. stock symbol ?

Winsan (Chengdu) Medical Science and Technology Co., Ltd. is a CN stock and trading under the symbol 600767.SS

What is Winsan (Chengdu) Medical Science and Technology Co., Ltd. stock quote today ?

Winsan (Chengdu) Medical Science and Technology Co., Ltd. stock price is $- today.

Is Winsan (Chengdu) Medical Science and Technology Co., Ltd. stock public?

Yes, Winsan (Chengdu) Medical Science and Technology Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Similar Market Cap